SGRY SHAREHOLDER BUYOUT INVESTIGATION: Kaskela Law is Investigating the Proposed Buyout of Surgery Partners, Inc. (SGRY) Shareholders at $23.50 Per Share - Fair Price or Insufficiently Low
ACCESSWIRE•27/10/2026•08:00 ET
0
Key Highlights
- ➤Surgery Partners agreed to HealthSpan Partners’ $23.50-per-share cash buyout
- ➤Analysts maintained Surgery Partners price targets above $28.00 when announced
- ➤Kaskela Law launched an investigation into whether the buyout price undervalues shares
- ➤Closing would cash out shareholders and end Surgery Partners’ public trading
PHILADELPHIA, PA / ACCESS Newswire / October 27, 2026 / Kaskela Law has launched an investigation into the fairness of the proposed buyout of Surgery Partners, Inc. (NASDAQ:SGRY) shareholders to determine whether the proposed $23.50 per share buyout price undervalues the company's shares.
Click here for additional information: https://kaskelalaw.com/case/surgery-partners/
Get started
Create a free account to read the full story.